Prolonged stimulation by follicle-stimulating hormone is required for the induction of ovarian follicular cysts by human chorionic gonadotropin in hypophysectomized rats

被引:7
|
作者
Bogovich, K
机构
来源
ENDOCRINE | 1996年 / 4卷 / 02期
关键词
ovarian cysts; PCO; FSH; androgens; estrogens; LUTEINIZING-HORMONE; PREGNANT RAT; CYCLING RATS; GROWTH; GRANULOSA; STEROIDOGENESIS; BIOSYNTHESIS; PROGESTERONE; PHYSIOLOGY; ESTRADIOL;
D O I
10.1007/BF02782755
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Combined stimulation by follicule-stimulating hormone (FSH) and subovulatory doses of human chorionic gonadotropin (hCG, luteinizing hormone [LH]-like activity) produces large ovarian follicular cysts in hypophysectomized (HYPOXD) immature rats. To obtain a better understanding of the extent to which stimulation by FSH is required in order for hCG to induce these ovarian cysts, immature HYPOXD rats were given subcutaneous (sc) injections of 1 IU hCG twice daily for 9 d, either alone or with daily injections of 2 mu g of highly purified ovine FSH on 1. Day one of hCG treatment; 2. Days one and two of hCG treatment; 3. Days one through five of hCG treatment; or 4. All 9 d of hCG treatment. Ovaries and serum samples were collected on the morning of d 10 of treatment. Animals that were treated for 9 d with hCG, but that received either no FSH or only 1 or 2 d of FSH treatment, did not display antral follicles on day 10 of treatment. The largest cross-sectional areas for the ovaries from animals that received 1 or 2 d of FSH treatments ranged between 6.84 +/- 0.51 mm(2) and 8.94 +/- 0.89 mm(2). The diameters of the largest preantral follicles in the ovaries of these two groups ranged between 0.278 +/- 0.011 and 0.320 +/- 0.028 mm, respectively. In contrast, ovaries from hCG-treated HYPOXD rats that received FSH treatments for either 5 or 9 d displayed follicular cysts by the morning of day 10. The largest cross-sectional areas for the ovaries from these two treatment groups were similar (15.68 +/- 1.61 and 18.7 +/- 5.13 mm(2), respectively), as were the mean diameters of the cystic follicles in these two groups (0.929 +/- 0.096 and 0.830 +/- 0.063 mm, respectively). Although serum androstenedione and testosterone concentrations were greater for HYPOXD rats that received combined FSH + hCG treatments than for animals that received hCC treatments alone, these concentrations did not increase with increasing numbers of days of FSH treatment. As with serum androstenedione and testosterone concentrations, serum estradiol and estrone concentrations for HYPOXD rats treated with hCG alone were limited (0.002 +/- 0.001 and 0.004 +/- 0.002 ng/mL, respectively), but had increased by day 10 after a single injection of FSH on day one of treatment. In contrast to serum androgen concentrations, serum estradiol and estrone concentrations continued to increase as the number of days of combined FSH + hCC treatment increased. These observations indicate that, in the rat, a significant period of exposure to tonic stimulation by both FSH and LH-like activity is required for the development of large ovarian cysts. Further, this period of exposure to FSH appears to be linked to increased peripheral serum estrogen concentrations, rather than to increased androgen concentrations. Therefore, the data provide indirect support for the concept that estrogens play a direct role, at the level of the ovary, in the induction of large ovarian cysts in the rat.
引用
收藏
页码:107 / 114
页数:8
相关论文
共 50 条
  • [31] Recombinant follicle-stimulating hormone versus human menopausal gonadotropin in the late follicular phase during ovarian hyperstimulation for in vitro fertilization
    Commenges-Ducos, M
    Piault, S
    Papaxanthos, A
    Ribes, C
    Dallay, D
    Commenges, D
    FERTILITY AND STERILITY, 2002, 78 (05) : 1049 - 1054
  • [32] Effects of follicle-stimulating hormone (FSH) and human chorionic gonadotropin in individuals with an inactivating mutation of the FSH receptor
    Vaskivuo, TE
    Aittomäki, K
    Anttonen, M
    Ruokonen, A
    Herva, R
    Osawa, Y
    Heikinheimo, M
    Huhtaniemi, I
    Tapanainen, JS
    FERTILITY AND STERILITY, 2002, 78 (01) : 108 - 113
  • [33] Luteinizing hormone-like and follicle-stimulating hormone-like activities of equine chorionic gonadotropin β-subunit mutants in cells expressing rat luteinizing hormone/chorionic gonadotropin receptor and rat follicle-stimulating hormone receptor
    Byambaragchaa, Munkhzaya
    Park, Ayoung
    Gil, So-Jin
    Lee, Hae-Won
    Ko, Yun-Jeong
    Choi, Seung-Hee
    Kang, Myung-Hwa
    Min, Kwan-Sik
    ANIMAL CELLS AND SYSTEMS, 2021, 25 (03) : 171 - 181
  • [34] FURTHER PURIFICATION OF THE FOLLICLE-STIMULATING HORMONE AND ITS EFFECT IN NORMAL AND HYPOPHYSECTOMIZED RATS
    MCSHAN, WH
    MEYER, RK
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1946, 61 (01): : 57 - 61
  • [35] Follicle-stimulating hormone is required for the initial phase of spermatogenic restoration in adult rats following gonadotropin suppression
    Meachem, SJ
    Wreford, NG
    Stanton, PG
    Robertson, DM
    McLachlan, RI
    JOURNAL OF ANDROLOGY, 1998, 19 (06): : 725 - 735
  • [36] Supplementation with a recombinant human chorionic gonadotropin microdose leads to similar outcomes in ovarian stimulation with recombinant follicle-stimulating hormone using either a gonadotropin-releasing hormone agonist or antagonist for pituitary suppression
    Cavagna, Mario
    Louzada Maldonado, Luiz Guilherme
    de Souza Bonetti, Tatiana Carvalho
    de Almeida Ferreira Braga, Daniela Paes
    Iaconelli, Assumpto, Jr.
    Borges, Edson, Jr.
    FERTILITY AND STERILITY, 2010, 94 (01) : 167 - 172
  • [37] STIMULATION OF OVARIAN FOLLICULAR MATURATION WITH PURE FOLLICLE-STIMULATING-HORMONE IN WOMEN WITH GONADOTROPIN-DEFICIENCY
    COUZINET, B
    LESTRAT, N
    BRAILLY, S
    FOREST, M
    SCHAISON, G
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 66 (03): : 552 - 556
  • [38] HYPERINSULINEMIA AND HUMAN CHORIONIC-GONADOTROPIN SYNERGISTICALLY PROMOTE THE GROWTH OF OVARIAN FOLLICULAR CYSTS IN RATS
    PORETSKY, L
    CLEMONS, J
    BOGOVICH, K
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1992, 41 (08): : 903 - 910
  • [39] FOLLICLE-STIMULATING HORMONE STIMULATION OF I-125 HUMAN CHORIONIC-GONADOTROPIN BINDING IN PORCINE GRANULOSA-CELL CULTURES
    CHANNING, CP
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1975, 149 (01): : 238 - 241
  • [40] Ovulation induction in the new millennium: Recombinant follicle-stimulating hormone versus human menopausal gonadotropin
    Al-Inany, H
    Aboulghar, MA
    Mansour, RT
    Serour, GI
    GYNECOLOGICAL ENDOCRINOLOGY, 2005, 20 (03) : 161 - 169